{
     "PMID": "11490180",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20011004",
     "LR": "20171101",
     "IS": "0302-282X (Print) 0302-282X (Linking)",
     "VI": "44",
     "IP": "2",
     "DP": "2001",
     "TI": "Chronic treatment with clozapine, but not haloperidol, increases striatal ecto-5'-nucleotidase activity in rats.",
     "PG": "99-102",
     "AB": "In the search for differential mechanisms underlying clozapine's superior antipsychotic efficacy, the purinergic system has been considered, since an antagonist of the adenosine receptor A(2A) was shown to block clozapine acute effects on c-fos expression in rat striatum. Further investigating the interaction of clozapine with the purinergic system, we studied the effects of chronic treatment (28 days, intraperitoneal) with clozapine (25 mg/kg) and haloperidol (1.5 mg/kg) on the activity of ectonucleotidases in the striatum and hippocampus of rats. Clozapine selectively increased striatal 5'-nucleotidase activity (22%) compared to control and haloperidol groups. In vitro, neither drug affected enzyme activities. These results reinforce the differential effects of clozapine compared to haloperidol on the purinergic system.",
     "CI": [
          "Copyright 2001 S. Karger AG, Basel"
     ],
     "FAU": [
          "Lara, D R",
          "Vianna, M R",
          "de Paris, F",
          "Quevedo, J",
          "Oses, J P",
          "Battastini, A M",
          "Sarkis, J J",
          "Souza, D O"
     ],
     "AU": [
          "Lara DR",
          "Vianna MR",
          "de Paris F",
          "Quevedo J",
          "Oses JP",
          "Battastini AM",
          "Sarkis JJ",
          "Souza DO"
     ],
     "AD": "Department of Biochemistry, Institute of Health Basic Science, UFRGS, Porto Alegre, Brazil. drlara@plug-in.com.br",
     "LA": [
          "eng"
     ],
     "PT": [
          "Comparative Study",
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "PL": "Switzerland",
     "TA": "Neuropsychobiology",
     "JT": "Neuropsychobiology",
     "JID": "7512895",
     "RN": [
          "0 (Antipsychotic Agents)",
          "415SHH325A (Adenosine Monophosphate)",
          "61D2G4IYVH (Adenosine Diphosphate)",
          "8L70Q75FXE (Adenosine Triphosphate)",
          "EC 3.1.3.5 (5'-Nucleotidase)",
          "J60AR2IKIC (Clozapine)",
          "J6292F8L3D (Haloperidol)"
     ],
     "SB": "IM",
     "MH": [
          "5'-Nucleotidase/*metabolism",
          "Adenosine Diphosphate/metabolism",
          "Adenosine Monophosphate/metabolism",
          "Adenosine Triphosphate/metabolism",
          "Animals",
          "Antipsychotic Agents/*pharmacology",
          "Clozapine/*pharmacology",
          "Haloperidol/*pharmacology",
          "Hippocampus/drug effects/metabolism",
          "Hydrolysis",
          "Male",
          "Neostriatum/drug effects/*enzymology",
          "Rats",
          "Rats, Wistar",
          "Synaptosomes/drug effects/metabolism"
     ],
     "EDAT": "2001/08/08 10:00",
     "MHDA": "2001/10/05 10:01",
     "CRDT": [
          "2001/08/08 10:00"
     ],
     "PHST": [
          "2001/08/08 10:00 [pubmed]",
          "2001/10/05 10:01 [medline]",
          "2001/08/08 10:00 [entrez]"
     ],
     "AID": [
          "54925 [pii]",
          "10.1159/000054925 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Neuropsychobiology. 2001;44(2):99-102. doi: 10.1159/000054925.",
     "term": "hippocampus"
}